clinical trial · NCT07019922
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Praxis Precision Medicines·phase3·recruiting·n = 50
Epileptic EncephalopathySCN2A Encephalopathy1mg elsunersensham procedure0.5mg elsunersen
brief summary
A Randomized, Multi-Center, Double-Blind, Sham-Procedure-Controlled Clinical Trial to Investigate the Efficacy and Safety of Elsunersen in Pediatric Participants with Early Onset SCN2A Developmental and Epileptic Encephalopathy
started
Aug 13, 2025
primary completion
Jun 1, 2026
completion
Dec 1, 2028
last updated
May 13, 2026
official title
A Randomized, Multi-Center, Double-Blind, Sham-Procedure-Controlled Clinical Trial to Investigate the Efficacy and Safety of Elsunersen in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol